Stamate C S, Andronescu A M, Nechita A C, Delcea C, Mihu E M, Vintila M M
1st Internal Medicine and Cardiology Department, "Sfantul Pantelimon" Clinical Emergency Hospital Bucharest ; "Carol Davila" University of Medicine and Pharmacy Bucharest.
1st Internal Medicine and Cardiology Department, "Sfantul Pantelimon" Clinical Emergency Hospital Bucharest.
J Med Life. 2013;6(4):409-13. Epub 2013 Dec 25.
The subclinical modification of thyroid function represents an important risk factor for the development of acute coronary syndromes, neglected up to this day. Knowledge of the physiopathological processes implicated in the alteration of thyroid function that induces cardiovascular dysfunction is a necessity for the understanding of the phenomena and for the finding of the adequate therapeutic solutions. While recognizing the thyroid dysfunction as a modifiable risk factor for the acute coronary syndrome, we encountered a new challenge for the clinical research regarding its implications. The ability to manage the altered thyroid homeostasis may represent a new stage of prevention at a population level for the reduction of the cardiac risk, a stage which implies a risk factor that may remain clinically mute for a long period of time if left undiagnosed, however influencing the development of the acute coronary syndromes.
甲状腺功能的亚临床改变是急性冠脉综合征发生的一个重要危险因素,至今仍被忽视。了解甲状腺功能改变导致心血管功能障碍所涉及的生理病理过程,对于理解这些现象和找到适当的治疗方案是必要的。在认识到甲状腺功能障碍是急性冠脉综合征的一个可改变的危险因素的同时,我们在临床研究中遇到了关于其影响的新挑战。管理甲状腺内环境稳态改变的能力可能代表了在人群层面预防心脏风险的一个新阶段,这个阶段意味着一个危险因素,如果不被诊断,可能在很长一段时间内临床上没有症状,但会影响急性冠脉综合征的发生。